FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 63 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,866,000 | +44.5% | 70,059 | +6.4% | 0.01% | +37.5% |
| Q2 2017 | $1,983,000 | -7.6% | 65,851 | +10.9% | 0.01% | -11.1% |
| Q1 2017 | $2,147,000 | -25.7% | 59,400 | +3.1% | 0.01% | -25.0% |
| Q4 2016 | $2,888,000 | +1.7% | 57,629 | +6.6% | 0.01% | 0.0% |
| Q3 2016 | $2,839,000 | +35.6% | 54,082 | +6.9% | 0.01% | +33.3% |
| Q2 2016 | $2,093,000 | +16.9% | 50,610 | +14.9% | 0.01% | +12.5% |
| Q1 2016 | $1,790,000 | -3.6% | 44,050 | -1.5% | 0.01% | 0.0% |
| Q4 2015 | $1,856,000 | +155.3% | 44,726 | -5.4% | 0.01% | +166.7% |
| Q3 2015 | $727,000 | -39.1% | 47,259 | -1.6% | 0.00% | -40.0% |
| Q2 2015 | $1,193,000 | +13.0% | 48,019 | +3.9% | 0.01% | +25.0% |
| Q1 2015 | $1,056,000 | +13.8% | 46,198 | +34.4% | 0.00% | 0.0% |
| Q4 2014 | $928,000 | +116.3% | 34,386 | -5.9% | 0.00% | +100.0% |
| Q3 2014 | $429,000 | -18.6% | 36,546 | +7.8% | 0.00% | 0.0% |
| Q2 2014 | $527,000 | +3.3% | 33,896 | +30.5% | 0.00% | 0.0% |
| Q1 2014 | $510,000 | +618.3% | 25,966 | +517.8% | 0.00% | – |
| Q4 2013 | $71,000 | – | 4,203 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eventide Asset Management | 601,000 | $24,587,000 | 1.39% |
| HealthCor Management, L.P. | 1,010,930 | $41,357,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 86,500 | $3,535,000 | 1.38% |
| PURA VIDA INVESTMENTS, LLC | 75,000 | $3,068,000 | 0.90% |
| BB BIOTECH AG | 777,500 | $31,808,000 | 0.88% |
| AWM Investment Company, Inc. | 100,000 | $4,091,000 | 0.71% |
| Granite Point Capital Management, L.P. | 50,000 | $2,046,000 | 0.43% |
| Rock Springs Capital Management LP | 217,700 | $8,906,000 | 0.41% |
| Crestline Management, LP | 50,919 | $2,083,000 | 0.29% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,432,700 | $99,522,000 | 0.24% |